Modern view on the treatment of urinary tract infections in pregnant women
Modern view on the treatment of urinary tract infections in pregnant women
A.A. Balushkina, N.E. Kan, V.L. Tutunnik
Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow
Despite achieved successes in recent years in diagnosis and treatment of urinary tract infections (UTI), they continue to be one of the most important areas of modern medicine. According to various data, almost every second woman in the world suffers an episode of UTI at least once in their life, 25–40% of that women over the next 6-12 months experience a relapse of the disease. In pregnant women, complications of UTI are: anemia, thrombocytopenia, preterm birth, placental insufficiency, intrauterine growth restriction, low birth weight and diseases of the urinary system, Infant Respiratory Distress Syndrome, pre-eclampsia, hypertension, increased incidence of purulent-septic complications in mother and fetus. In this regard, it is important to conduct timely and adequate treatment of this pathology.
Given the need to avoid negative effects on mother, fetus and newborn body, fosfomycin (e.g., Fosfomycin Esparma) in a single dose is a first-line drug for the empirical treatment of uncomplicated UTI in young and middle-aged women and pregnant women, exceeding in application convenience of fluroquinolone, nitrofuran and inhibitor-protected aminopenicillins.
Key words: urinary tract infections, pregnancy, asymptomatic bacteriuria, cystitis, fosfomycin, Fosfomycin Esparma.
For citation: Balushkina A.A., Kan N.E., Tutunnik V.L. Modern view on the treatment of urinary tract infections in pregnant women // RMJ. Medical Review. 2018. № 8(I). P. 37–40.
References
1. Foxman B., Barlow R., D’Arcy H. et al. Urinary tract infection: self-reported incidence and associated costs // Ann. Epidemiol. 2010. Vol. 10(8). P.509–515.
2. Gupta K., Hooton T.M., Naber K.G. et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases // Clinical Infectious Diseases. 2011. Vol. 52(5). Р.e103–e120. DOI: 10.1093/cid/ciq257
3. Перепанова Т.С. Федеральные клинические рекомендации-2015. Антимикробная терапия и профиликтика инфекций почек, мочевыводящих путей и мужских половых органов // Терапевтический архив. 2016. №88(4). С.100–104 [Perepanova T.S. Federal’nye klinicheskie rekomendacii-2015. Antimikrobnaja terapija i profiliktika infekcij pochek, mochevyvodjashhih putej i muzhskih polovyh organov // Terapevticheskij arhiv. 2016. №88(4). S.100–104 (in Russain)].
4. Беременность и роды при заболеваниях мочевыводящих органов / под ред. Г.Т. Сухих. М.: 2009. 432 с. [Beremennost’ i rody pri zabolevanijah mochevyvodjashhih organov / pod red. G.T. Suhih. M., 2009. 432 s. (in Russain)].
5. Leeper C., Lutzkanin A. Infections During Pregnancy // Prim. Care. 2018. Vol. 45(3). P.567–586.
6. Локшин К.Л. Сравнительная эффективность стандартной антибиотикотерапии и терапии препаратом Канефрон Н бессимптомной бактериурии у беременных // Урология. 2018. №3. С.54–57 [Lokshin K.L. Sravnitel’naja jeffektivnost’ standartnoj antibiotikoterapii i terapii preparatom Kanefron N bessimptomnoj bakteriurii u beremennyh // Urologija. 2018. №3. S.54–57 (in Russain)].
7. Урология. Российские клинические рекомендации / под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. М.: ГЭОТАР-Медиа, 2016. 496 с. [Urologija. Rossijskie klinicheskie rekomendacii / pod red. Ju.G. Aljaeva, P.V. Glybochko, D.Ju. Pushkarja. M.: GJeOTAR-Media. 2016. 496 s. (in Russian)].
8. Dautt-Leyva J.G., Canizalez-Román A., Acosta Alfaro L.F. et al. Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli // J. Obstet. Gynaecol. Res. 2018. Vol. 44(8). P. 1384–1390.
9. Ghouri F., Hollywood A., Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy // BMC Pregnancy Childbirth. 2018. Vol. 18(1). P.99.
10. Yagel Y., Nativ H., Riesenberg K. et al. Outcomes of UTI and bacteriuria caused by ESBL vs. non-ESBL Enterobacteriaceae isolates in pregnancy: a matched case-control study // Epidemiol. Infect. 2018. Vol. 146(6). P.771–774.
11. Romero R., Oyarzun E., Mazor M. et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight // Obstet. Gynecol. 2009. Vol. 73. P.576–582.
12. Smaill F. Antibiotics for asymptomatic bacteriuria during pregnancy // Cochrane Database Syst. Rev. 2010. Vol. 2. CD000490. DOI:10.1002/14651858.cd000490.pub2
13. Smaill F.M., Vazquez J.C. Antibiotics for asymptomatic bacteriuria during pregnancy // Cochrane Database Syst. Rev. 2015. Vol. 8. CD000490. DOI: https://doi.org/10.1002/14651858.cd000490.pub3
14. Lai Y.J., Hsu T.Y., Lan K.C. et al. Asymptomatic pyuria in pregnant women during the first trimester is associated with an increased risk of adverse obstetrical outcomes // Taiwan J. Obstet. Gynecol. 2017. Vol. 56(2). P.192–195.
15. Nicolle L.E.. Asymptomatic bacteriuria // Curr. Opin. Infect. Dis. 2014. Vol. 27(1). P.90–96.
16. Bayrak O., Cimentepe E., Inegöl I. et al. Is single- dose fosfomycintrometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy? // Int. Urogynecol. J. 2007. Vol. 18. P.525–529.
17. Estebanez A., Pascual R., Gil V. Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy // Eur. J. Clin. Microbiol. Infect. Dis. 2009. Vol. 28. P.1457–1464.
18. Zhanel G.G., Walkty A.J., Karlowsky J.A. Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis // Can. J. Infect. Dis. Med. Microbiol. 2016. 2082693. DOI: 10.1155/2016/2082693
19. Guidelines on Urological Infections / ed. by Grabe M., Bartoletti R., Bjerklund Johansen T.E. et al. European Association of Urology. 2015. 86 p.
20. Kalinderi K., Delkos D., Kalinderis M. et al. Urinary tract infection during pregnancy: current concepts on a common multifaceted problem // J. Obstet. Gynaecol. 2018. Vol. 38(4). P.448–453.
21. Ailes E.C., Summers A.D., Tran E.L. et al. Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections — United States, 2014 // MMWR Morb. Mortal Wkly Rep. 2018. Vol. 67(1). P.18–22.
22. The sanford guide to antimicrobal therapy / ed. by Gilbert D.N., Moellering R.C., Eliopoulus G.M. et al. Antimicrobal therapy. Inc. USA. 2010. 219 p.
23. Shepherd A.K., Pottinger P.S. Management of Urinary Tract Infections in the Era of Increasing Antimicrobial Resistance // Med. Clin. N. Am. 2013. Vol. 97. P.737–757.
24. Treatment of urinary tract infections in nonpregnant women. (ACOG practice bulletin; no. 91) / Washington (DC): American College of Obstetricians and Gynecologists (ACOG). 2008. 10 p.
25. Widmer M., Lopez I., Gülmezoglu A.M. et al. Duration of treatment for asymptomatic bacteriuria during pregnancy // Cochrane Database Syst. Rev. 2015. Vol. 11. CD000491. DOI: 10.1002/14651858.CD000491.pub2
26. Kоves B., Cai T., Veeratterapillay R. et al. Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel // Eur. Urol. 2017. Vol. 72(6). P.865–868.
27. Keating G.M. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria // Drugs. 2013. Vol. 73(17). P.1951–1966.
28. Фосфомицин Эспарма, инструкция по применению лекарственного препарата для медицинского применения, 2018 [Fosfomicin Jesparma, instrukcija po primeneniju lekarstvennogo preparata dlja medicinskogo primenenija, 2018 (in Russian)]. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=6272f09b-6da9-409d-9c28-0f527323f87fandt= (дата обращения: 08.10.2018).
29. Клотримазол, инструкция по применению лекарственного препарата для медицинского применения, 2018 [Klotrimazol, instrukcija po primeneniju lekarstvennogo preparata dlja medicinskogo primenenija, 2018 (in Russian)]. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4ec47bd2-66f5-45b6-bb72-6ee210e3649dandt= (дата обращения: 08.10.2018).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
